Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.

NCT00280592 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT00280592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00280592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.
Lead sponsor
Rennes University Hospital
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
October 31, 2008
Enrollment
171 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

bladder dysfunction, multiple sclerosis, urinary tract infections